Skip to main content
. Author manuscript; available in PMC: 2018 Jan 18.
Published in final edited form as: Am J Transplant. 2018 Jan;18(Suppl 1):18–113. doi: 10.1111/ajt.14557

Figure KI 111. mTOR inhibitor use in pediatric kidney transplant recipients.

Figure KI 111

Immunosuppression at transplant reported to the OPTN. One-year posttransplant data are limited to patients alive with graft function at 1 year posttransplant. mTOR, mammalian target of rapamycin.